Redwire Corp Secures $25M NASA Contract for Biotechnology Services on ISS
ByAinvest
Friday, Aug 29, 2025 7:19 pm ET1min read
RDW--
Redwire Corp has been awarded a $25 million NASA contract to provide biotechnology services for the International Space Station. The contract will enable Redwire to support drug development investigations using its PIL-BOX technology. The company has received a $2.5 million task order under the contract. Redwire's focus on space biotechnology and partnerships with major pharmaceutical companies position it well in a niche but expanding market. The indefinite nature of the contract means revenue realization will depend on the number and size of task orders issued.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet